Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

The Cameron Boyce Foundation to Join the CURE Epilepsy Family


News provided by

CURE Epilepsy

Aug 04, 2026, 13:30 ET

Share this article

Share toX

Share this article

Share toX


CURE Epilepsy will serve as the long-term steward of The Cameron Boyce Foundation's legacy in epilepsy, providing scientific leadership and infrastructure to further the impact of the Foundation's important work across community-building, awareness, and research.

CHICAGO, Aug. 4, 2026 /PRNewswire-PRWeb/ -- CURE Epilepsy, the largest nongovernmental funder of epilepsy research, today announces that The Cameron Boyce Foundation (TCBF) will be joining its family. The collaboration brings together two organizations long aligned in their commitment to epilepsy research and awareness, particularly around Sudden Unexpected Death in Epilepsy (SUDEP).

Cameron Boyce was an actor and humanitarian best known for his roles as Luke in Disney Channel's "Jessie" and as Carlos in the Disney Channel original movie franchise "Descendants." He passed away from SUDEP in 2019 at the age of 20. Following his death, his family founded TCBF to honor his legacy and support causes close to his heart, including epilepsy research.

The collaboration brings together two organizations long aligned in their commitment to epilepsy research and awareness, particularly around Sudden Unexpected Death in Epilepsy (SUDEP).

Post this

Since its founding, TCBF has raised $2 million to advance epilepsy research, awareness, and community support. This included hosting three Cam for a Cause events in Los Angeles attended by leaders in entertainment and philanthropy, with actors such as Adam Sandler serving on TCBF's Advisory Board. Almost a quarter of total dollars raised were used to fund CURE Epilepsy research grants.

CURE Epilepsy has funded over $6 million in SUDEP research across 40 grants. Their most recent grant mechanism, the SUDEP Clinical Biomarker Team Science Award, provides $750,000 of funding to three multidisciplinary research teams to mine international clinical databases for SUDEP risk factors.

"Over the past three decades, I have met countless families who — having lost loved ones to epilepsy — have joined with CURE Epilepsy to play critical roles in catalyzing awareness and research funding. When I first met Libby Boyce, I knew instantly that the wound she and her family felt after the loss of Cameron would motivate an unstoppable force for change. It is truly an honor to join forces with TCBF and the Boyce family to accelerate progress toward ending the devastation that epilepsy has brought to so many of us," said Susan Axelrod, CURE Epilepsy's founder.

Going forward, CURE Epilepsy will serve as the long-term steward of Cameron's legacy in epilepsy, providing scientific leadership and infrastructure to expand the reach and impact of his work. As part of the transition, Cameron's mother, Libby Boyce, will join the CURE Epilepsy Board of Directors. "Joining with CURE Epilepsy, a longtime and trusted partner, amplifies Cameron's impact in epilepsy, giving it scale and long‑term sustainability—while allowing TCBF's advocacy, education, and storytelling to reach new audiences and fuel groundbreaking research for years to come," she said.

Through this partnership, TCBF will continue to engage its community in a manner that reflects its own voice, history, and perspective. Signature programs such as the Foundation's Now What epilepsy support groups will continue, as will TCBF's social media channels, preserving the authentic connection Cameron inspired.

"The Cameron Boyce Foundation's legacy lives on, now supported by CURE Epilepsy's research leadership and infrastructure," said CURE Epilepsy CEO Beth Dean. "We thank Libby and Victor for entrusting us with this important responsibility and opportunity to further our joint missions. Together, we are building a stronger, broader movement toward our shared goal of finding a cure for epilepsy."

About CURE Epilepsy

CURE Epilepsy is a parent-founded, research-focused nonprofit committed to finding a cure for epilepsy. Since 1998, we have invested in cutting-edge research and filled critical funding gaps in foundational science to expand our understanding of the underlying mechanisms of epilepsy and help us discover a cure. We have raised more than $100 million and funded over 300 epilepsy research projects — more than any other nongovernmental organization in the United States.

About The Cameron Boyce Foundation

The Cameron Boyce Foundation (est. 2019) honors Cameron's legacy by empowering young adults living with epilepsy through education, support, and community, while working to end SUDEP.

Media Contact

Dana Vielmetti, CURE Epilepsy, 1 312.971.8443, [email protected], https://www.cureepilepsy.org/

Heather Kun, The Cameron Boyce Foundation, [email protected], https://www.thecameronboycefoundation.org/

SOURCE CURE Epilepsy

Modal title

Cameron Boyce
Cameron Boyce
Cameron Boyce

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.